In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kipchu Tshering, Mir Misbahuddin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Seri Bilgileri:Bangabandhu Sheikh Mujib Medical University Journal
Konular:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Online Erişim:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller